Oskar Hemmingsson

Senior lecturer, deputy/specialist physician at Department of Surgical and Perioperative Sciences
Surgery

Publications

Author

Title

Year sorteringsordning

Fulltext

Caini, Saverio
Masala, Giovanna
Saieva, Calogero; et al.

Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, 140(10): 2246-2255

2017

-

Rutegård, Martin
Hassmén, N
Hemmingsson, Oskar; et al.

Anterior Resection for Rectal Cancer and Visceral Blood Flow: An Explorative Study
Scandinavian Journal of Surgery, 105(2): 78-83

2016

-

Hughes, David J.
Duarte-Salles, Talita
Hybsier, Sandra; et al.

Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
American Journal of Clinical Nutrition, 104(2): 406-414

2016

-

Duarte-Salles, Talita
Misra, Sandeep
Stepien, Magdalena; et al.

Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
Cancer Prevention Research, 9(9): 758-765

2016

-

Boussemart, Lise
Malka-Mahieu, Hélène
Girault, Isabelle; et al.

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Nature, 513(7516): 105-109

2014

-

Natarajan, Balasubramanian
Gaur, Rahul
Hemmingsson, Oskar; et al.

Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin
Worm, 2(1)

2013

-

Rutegård, Martin
Hemmingsson, Oskar
Matthiessen, P.; et al.

High tie in anterior resection for rectal cancer confers no increased risk of anastomotic leakage
British Journal of Surgery, 99(1): 127-132

2012

-

Hemmingsson, Oskar

ASNA1 and cisplatin resistance: studies in C. elegans and in human tumor cells

2010

Download

Hemmingsson, Oskar
Kao, Gautam
Still, Maria; et al.

ASNA-1 activity modulates sensitivity to cisplatin
Cancer Research, 70(24): 10321-10328

2010

-

Hemmingsson, Oskar
Nöjd, Mikael
Kao, Gautam; et al.

Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1
Oncology Reports, 22(4): 869-875

2009

-